UTP14C
Basic information
Region (hg38): 13:52024691-52033600
Previous symbols: [ "KIAA0266" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the UTP14C gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 42 | 45 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 19 | 14 | 39 | |||
Total | 1 | 3 | 63 | 15 | 6 |
Variants in UTP14C
This is a list of pathogenic ClinVar variants found in the UTP14C region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
13-52024711-TAAG-T | ALG11-congenital disorder of glycosylation | Conflicting classifications of pathogenicity (Aug 29, 2022) | ||
13-52024717-G-A | ALG11-congenital disorder of glycosylation | Likely benign (May 23, 2023) | ||
13-52024721-G-T | ALG11-congenital disorder of glycosylation | Uncertain significance (Feb 15, 2019) | ||
13-52024738-G-A | Likely benign (Jul 23, 2018) | |||
13-52024759-A-G | ALG11-congenital disorder of glycosylation | Uncertain significance (Jan 13, 2018) | ||
13-52024762-T-G | not specified • ALG11-congenital disorder of glycosylation | Benign/Likely benign (Jan 18, 2024) | ||
13-52024764-G-T | ALG11-congenital disorder of glycosylation | Uncertain significance (Jan 12, 2018) | ||
13-52024766-C-T | ALG11-congenital disorder of glycosylation | Uncertain significance (-) | ||
13-52024767-G-A | ALG11-congenital disorder of glycosylation | Uncertain significance (Aug 16, 2022) | ||
13-52024804-A-G | Likely benign (Apr 23, 2018) | |||
13-52024837-T-C | ALG11-congenital disorder of glycosylation • not specified | Benign/Likely benign (Nov 27, 2023) | ||
13-52024851-TAAAC-T | Pathogenic (Jan 26, 2016) | |||
13-52024872-T-C | ALG11-congenital disorder of glycosylation | Pathogenic (Mar 01, 2012) | ||
13-52024890-A-C | ALG11-congenital disorder of glycosylation | Uncertain significance (Feb 17, 2022) | ||
13-52024913-A-G | Uncertain significance (Feb 03, 2014) | |||
13-52024914-T-C | ALG11-congenital disorder of glycosylation | Likely pathogenic (-) | ||
13-52024921-C-T | ALG11-congenital disorder of glycosylation | Likely benign (Nov 30, 2020) | ||
13-52024922-G-A | ALG11-congenital disorder of glycosylation | Pathogenic (Mar 01, 2012) | ||
13-52024999-A-G | not specified | Benign (Jul 31, 2024) | ||
13-52028094-T-A | Likely benign (Dec 19, 2019) | |||
13-52028094-T-TA | Likely benign (Dec 03, 2020) | |||
13-52028305-G-T | ALG11-congenital disorder of glycosylation | Likely benign (Dec 22, 2020) | ||
13-52028312-T-C | ALG11-congenital disorder of glycosylation | Likely benign (Dec 22, 2020) | ||
13-52028313-T-C | ALG11-congenital disorder of glycosylation | Conflicting classifications of pathogenicity (Aug 17, 2023) | ||
13-52028325-T-C | ALG11-congenital disorder of glycosylation | Uncertain significance (Jan 13, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
UTP14C | protein_coding | protein_coding | ENST00000521776 | 1 | 8910 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00535 | 0.994 | 125547 | 1 | 200 | 125748 | 0.000800 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.472 | 398 | 372 | 1.07 | 0.0000197 | 5049 |
Missense in Polyphen | 104 | 99.541 | 1.0448 | 1532 | ||
Synonymous | 0.601 | 136 | 145 | 0.937 | 0.00000782 | 1476 |
Loss of Function | 2.88 | 8 | 22.9 | 0.350 | 0.00000118 | 321 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000514 | 0.000514 |
Ashkenazi Jewish | 0.00576 | 0.00567 |
East Asian | 0.000762 | 0.000761 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000422 | 0.000422 |
Middle Eastern | 0.000762 | 0.000761 |
South Asian | 0.00353 | 0.00213 |
Other | 0.000816 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Essential for spermatogenesis. May be required specifically for ribosome biogenesis and hence protein synthesis during male meiosis (By similarity). {ECO:0000250, ECO:0000269|PubMed:15289605}.;
- Pathway
- Ribosome biogenesis in eukaryotes - Homo sapiens (human);rRNA processing;Metabolism of RNA;rRNA modification in the nucleus and cytosol;rRNA processing in the nucleus and cytosol
(Consensus)
Intolerance Scores
- loftool
- rvis_EVS
- 0.11
- rvis_percentile_EVS
- 62.1
Haploinsufficiency Scores
- pHI
- hipred
- N
- hipred_score
- 0.158
- ghis
- 0.486
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.247
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Utp14b
- Phenotype
- reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- rRNA processing;multicellular organism development;spermatogenesis;cell differentiation;meiotic cell cycle
- Cellular component
- nucleolus;cytosol;small-subunit processome
- Molecular function
- protein binding